Ana C Oliveira (Ana C De Oliveira)

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 2

Top Topics

Placebo Controlled

Lymph Node Metastasis

Acute Lymphoblastic Leukemia

Top Venues

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

International journal of hematology

This page only lists publications with an associated author ORCID identifier.

Publications

Pier Luigi Luigi Zinzani, Jiří Mayer, Christopher R Flowers, Fontanet Bijou, Ana C Oliveira, Yuqin Song, Qingyuan Zhang, Michele Merli, Krimo Bouabdallah, Peter Ganly, Huilai Zhang, Roderick Johnson, Alejandro Martin Martin Garcia-Sancho, Mariano Provencio Pulla, Marek Trněný, Sam Yuen, Herve Tilly, Edwin Kingsley, Gayane Tumyan, Sarit E Assouline, Rebecca Auer, Elena Ivanova, Pil Kim, Sha Huang, Richard Delarue, Judith Trotman
ROSEWOOD: A Phase II Randomized Study of Zanubrutinib Plus Obinutuzumab Versus Obinutuzumab Monotherapy in Patients With Relapsed or Refractory Follicular Lymphoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Ana C Oliveira, Josep Maria Roncero, Christelle Ferrá, Janilson Do Nascimento, Marta Rodriguez-Luaces, Maite Encuentra, Eva Domingo-Domenech, Patricia López, David Gallardo, Josep Maria Ribera, Josep Sarrá, Anna Sureda, Eva González-Barca
Front-line fludarabine-cyclophosphamide-rituximab (FCR) in 110 patients with chronic lymphocytic leukaemia (CLL): real-life experience with long-term outcomes, toxicities and responses to second-line therapies. International journal of hematology (2022)